About
Mitchell Lee is a longevity scientist and the CEO and co-founder of Ora Biomedical, a Seattle-area biotechnology company developing small-molecule therapeutics for healthy aging using high-throughput phenotypic screening. He is also publicly associated with LongX's Xplore Program as a mentor/speaker figure within longevity education and career development. Public materials place him at the intersection of aging biology, drug discovery, and longevity ecosystem building rather than fund management or angel investing.
Areas of interest
longevityaging biologybiotechdrug discoverysmall-molecule therapeuticshealthspanphenotypic screeningAI for drug discoverygeroscience